-

Medable Announces Partnership with Withings Health Solutions to Integrate Connected Health Devices in Decentralized Clinical Trials

Withings medical-grade sensors within user-friendly devices regularly capture accurate measurements vital to most therapeutic areas

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading SaaS platform provider for patient-centered clinical trials, today announced a new partnership with Withings Health Solutions, the business-to-business division of Withings, one of the global leaders in at-home connected health. Withings’ devices will seamlessly connect to Medable’s decentralized clinical trial platform, reducing the burden on sponsors and sites while empowering patients to participate in trials from home.

With Withings easy-to-use devices, Medable can remotely capture and integrate critical medical-grade measurements, including temperature, heart rate, blood pressure, sleep patterns, and weight. Withings incorporates patient-centered design principles to develop non-invasive devices that are both robust and easy for patients to use in any setting. The convenience can improve patient recruitment and retention – which is significant since 85% of clinical trials fail to retain enough patients and more than two-thirds of sites fail to meet patient enrollment goals.

“Medable has significantly contributed to improving the way clinical trials are run and shares our focus on usability and patient experience. We are very proud to partner with them to bring our devices to their decentralized clinical trials platform,” said Antoine Robiliard, VP Health Solutions, at Withings. “Together, we can increase operational efficiencies and enhance the patient experience in clinical trials.”

With Withings devices integrated into Medable’s DCT platform, Medable eliminates siloed data streams, delivering aggregate patient data in one platform to improve trial oversight for sponsors. Sites also gain immediate access to data insights within the Medable platform, consolidated for every patient in a study.

Medable was founded by Dr. Michelle Longmire, who wanted to solve the problem of limited participant access to clinical trials. Medable’s platform has revolutionized how clinical trials are conducted, allowing people across demographics to participate remotely in decentralized and hybrid clinical trials.

“As the industry leader in plug-and-play connected sensor devices, Withings is the ideal partner for Medable as we continue driving for population representation in clinical trials,” said Dr. Michelle Longmire, co-founder and CEO of Medable. “Their devices are a critical part of a successful decentralized clinical trial – the third leg of the DCT stool – and we look forward to a long, successful partnership with Withings.”

About Medable

Medable is on a mission to get effective therapies to patients faster by transforming clinical drug development with disruptive technologies. The company’s digital platform streamlines design, recruitment, retention and data quality for decentralized trials, replacing siloed systems with integrated digital tools, data and interfaces to accelerate trial execution. Medable connects patients, sites and clinical trial teams to improve patient access, experience, and outcomes. Medable is a privately held, venture-backed company headquartered in Palo Alto, California.

About Withings Health Solutions

Health Solutions is a dedicated division of connected health leader Withings, serving healthcare professionals across chronic disease prevention and management, remote patient monitoring, clinical research, and more. Its mission is to bridge the gap between patients and their care teams by continuously and effortlessly providing healthcare professionals with medical-grade data generated by patients from an ecosystem of connected devices. The Withings portfolio includes connected scales, blood pressure monitors, an advanced sleep system, a smart temporal thermometer, and hybrid smartwatches. It also includes data connectivity options as well as a remote patient monitoring platform. For more than a decade, Withings has built an expertise in user experience, engagement, and retention. Withings Health Solutions extends this expertise to the healthcare industry to remove friction in the patient's journey and allow for digital health to expand. For more information, visit: www.withingshealthsolutions.com

Contacts

Lisa Barbadora, Barbadora INK for Medable
+1 (610) 420-3413
lbarbadora@barbadoraink.com / media@medable.com

Ian Twinn, Tandem Comms for Withings Health Solutions
+1 (917) 306 7270
iantwinn@tandemcomms.com

Medable Inc.

Details
Headquarters: Palo Alto, California
CEO: Michelle Longmire
Employees: 350
Organization: PRI

Release Versions

Contacts

Lisa Barbadora, Barbadora INK for Medable
+1 (610) 420-3413
lbarbadora@barbadoraink.com / media@medable.com

Ian Twinn, Tandem Comms for Withings Health Solutions
+1 (917) 306 7270
iantwinn@tandemcomms.com

More News From Medable Inc.

Medable CEO Michelle Longmire Featured as Guest Speaker with Leaders from Google and Mayo Clinic at Japan’s Largest Pharmaceutical Summit

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology platform for agentic AI clinical development, today announced that its CEO and co-founder, Dr. Michelle Longmire, will be one of three international guest speakers at Japan’s largest pharmaceutical conference, Ubie Pharma Summit (May 13-14, 2026). Longmire will be speaking at the fifth annual event along with Justin Chen, MD, Clinical Specialist at Google for Health, and John Halamka, MD, President of Mayo Clinic Platform....

Medable Introduces AI Agent to Reduce Burden at Research Sites By Assisting Principal Investigators with Oversight of eCOA Data

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology platform for AI-powered clinical development, today launched Agentic AI for research sites to reduce burden and assist principal investigators (PIs) in oversight and monitoring of electronic clinical outcome assessment (eCOA) data. Medable’s newest agent integrates seamlessly within its eCOA system workflows. Released just after Medable’s TMF and CRA agents, its PI Summary Agent continues the company’s rapid rollout of fun...

Medable Debuts AI Agent for Automating Trial Master File (TMF) Processes

PALO ALTO, Calif.--(BUSINESS WIRE)--Medable Inc., the leading technology platform for AI-powered clinical development, today announced its TMF Agent, which brings artificial intelligence and automation to the labor-intensive processes required for trial document management. TMF Agent significantly improves quality and consistency while drastically reducing the manual effort in document management. It is built on Medable’s Agent Studio, the industry’s first agentic AI platform for clinical devel...
Back to Newsroom